Fig. 1From: Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in TaiwanSurvival curves in patients with brain metastases from NSCLC for the various treatment regimens. a Survival curve for the whole population. b Survival cure for male study patients alone. c Survival curve for female study patients alone. WBRT, WBRT+ gefitinib, WBRT+ GK, WBRT+GK+ gefitinib: see textBack to article page